MedPath

Prospective, clinical, multicentric study to evaluate the influence of the length of the membranous urethra on stress urinary incontinence after robot-assisted radical prostatectomy

Conditions
C61
Malignant neoplasm of prostate
Registration Number
DRKS00024607
Lead Sponsor
Krankenhaus der Barmherzigen Brüder Wien
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
500
Inclusion Criteria

Informed consent
- Minimum age: 18 years
- Locally confined prostate cancer
- mpMRI/MR abdomen presurgically; T2w sagittal plane
- RARP technique

Exclusion Criteria

- Missing informed consent
- Missing ability to give consent
- Presurgery of prostate gland
- Surgery as Salvageprostatectomy
- Patients with adjuvant radiation therapy

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ower SUI after RARP in patients with longer M
Secondary Outcome Measures
NameTimeMethod
- Further criteria leading to SUI after RARP<br>- Impact of MUL on irritative/obstructive urinary tract symptoms<br>- Impact on bowel, sexual, hormonal features<br>- Interobserver validity of MUL measurement<br>- Influence of apex shape on incontinence
© Copyright 2025. All Rights Reserved by MedPath